Li, Jun, Ye, Lin ORCID: https://orcid.org/0000-0002-0303-2409, Sun, Ping-Hui, Zheng, Fei, Ruge, Fiona, Satherley, Lucy, Feng, Yi ORCID: https://orcid.org/0000-0002-2445-1290, Zhao, Huishan, Du, Guifang, Wang, Tingting, Yang, Yao, Ma, Xuemei, Cheng, Shan, Yang, Xiaomei, Yu, Hefen, Teng, Xu, Si, Yang, Zhang, Zhongtao and Jiang, Wen ORCID: https://orcid.org/0000-0002-3283-1111 2017. Reduced NOV expression correlates with disease progression in colorectal cancer and is associated with survival, invasion and chemoresistance of cancer cells. Oncotarget 10.18632/oncotarget.15439 |
Preview |
PDF
- Published Version
Available under License Creative Commons Attribution. Download (3MB) | Preview |
Preview |
PDF
- Supplemental Material
Available under License Creative Commons Attribution. Download (1MB) | Preview |
Abstract
Aberrant expression of nephroblastoma overexpressed (NOV) has been evident in certain malignancies. In the current study, we aim to investigate the role played by NOV in colorectal cancer (CRC). NOV expression was determined in a cohort of 359 CRC tissues and 174 normal colorectal tissues. Its impact on CRC cells was investigated using in vitro NOV knockdown and overexpression models. NOV transcripts were reduced in the CRC tumours compared with the paired adjacent normal colorectal tissues (p < 0.01) and was associated with distant metastases. NOV knockdown resulted in increased cell proliferation and invasion of RKO cells, whilst an opposite effect was seen in the HT115 NOV over expressing cells. A positive association between Caspase-3/-8 and NOV was seen in NOV knockdown and overexpression cell lines which contributed to the survival of serum deprived CRC cells. Further investigation showed that NOV regulated proliferation, survival and invasion through the JNK pathway. NOV knockdown in RKO cells reduced the responsiveness to 5-Fluorouracil treatment, whilst overexpression in HT115 cells exhibited a contrasting effect. Taken together, NOV is reduced in CRC tumours and this is associated with disease progression. NOV inhibits the proliferation and invasion of CRC cells in vitro. Inhibition of proliferation is mediated by a regulation of Caspase-3/-8, via the JNK pathway, which has potential for predicting and preventing chemoresistance.
Item Type: | Article |
---|---|
Date Type: | Published Online |
Status: | Published |
Schools: | Medicine |
Subjects: | R Medicine > R Medicine (General) |
Uncontrolled Keywords: | NOV, colorectal cancer, JNK signalling pathways, proliferation, invasion |
Publisher: | Impact Journals |
ISSN: | 1949-2553 |
Funders: | the National Key Clinical Specialist construction Programs of China, Cancer Research Wales, the Chinese Medical Research Scholarship of Cardiff University |
Date of First Compliant Deposit: | 21 February 2017 |
Date of Acceptance: | 6 February 2017 |
Last Modified: | 11 Oct 2023 19:59 |
URI: | https://orca.cardiff.ac.uk/id/eprint/98180 |
Citation Data
Cited 7 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
Edit Item |